Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Wang (Beijing, China). One year change in health status in patients with stable Chronic Obstructive Pulmonary Disease (COPD) under long-acting bronchodilators treatment. 1813

Member's Comments

No comment yet.

Related content which might interest you: Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Cardiovascular safety of fixed dose combination long acting bronchodilators in stable patients with Chronic Obstructive Pulmonary Disease. Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Do GOLD stages of COPD severity really correspond to differences in health status? Source: Eur Respir J 2003; 22: 444-449 Year: 2003 Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 178s Year: 2002 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Rate of FVC decline in a primary care UK Chronic Obstructive Pulmonary Disease (COPD) population Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 The cost benefit of initiating domiciliary Non-invasive Ventilation (NIV) as an outpatient is accompanied by good clinical outcomes for hypercapnic Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: management Year: 2010 Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease Year: 2020 Effectiveness of indacaterol with or without tiotropium in patients with moderate or severe chronic obstructive pulmonary disease (COPD) - the GOLDEN II study Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Tiotropium in chronic obstructive pulmonary disease: Gender differences in outcomes Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations Source: Eur Respir J 2013; 41: 12-17 Year: 2013